This work brings new insights in the transcription levels of some cancer-related genes, namely TP53, CCND1, FUS, YBX1, PTBP1, c-MYC and PKM2 in FMCs following an approach that overcome the germline polymorphisms (since the disease-free tissue from the same animal was used as reference). This evidence concerns the gene TP53 and cancer.